Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
James Chase
Recent Articles
When no news is bad news
May 01, 2012
Like it or not, you have an obligation to communicate with your stakeholders
Genentech gives MR a psychodynamic focus
May 01, 2012
Genentech is thinking outside the traditional focus group to better understand patients which, in turn, is helping address adherence and brand preference.
MM&M Awards: Dream Team 2012
May 01, 2012
This year's judges for the MM&M Awards once again represent the cream of the industry's leaders and thinkers. But this year, there are twice as many of them. Find out who made it onto the panel
Headliner: Hayes' open-door policy opens doors
May 01, 2012
Tim Hayes, President, Bayer HealthCare Consumer Care North America
Hope-infested waters
April 01, 2012
Pharma has made advances in solving health problems and that's where the future lies
Genentech's mind-tapping science moves needle on Pulmozyme, Tamiflu
March 28, 2012
Genentech is thinking outside the traditional focus group to understand patients, helping address the long-standing business challenges of adherence and brand preference, the firm says.
MM&M Awards 2012: How to Win an Award
March 01, 2012
James Chase asked 16 of last year's judges about how entrants can improve their chances of winning an MM&M Award
MAHF Inductees 2012: Heroes' Welcome
March 01, 2012
It was a night to remember as the stars of medical advertising came out to welcome three more legends into the Hall of Fame
Desperate measures
March 01, 2012
Researchers are sensing a waning influence within their companies
Gamification: Game On
February 06, 2012
Applying game dynamics to non-game environments creates opportunities to engage people and exert behavioral changes with unprecedented success. James Chase reports
« Previous
Next »
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
Makers of pain pills, advocacy groups at center of Senate probe
Saatchi shop rebrands to sharpen specialty focus
RX-to-OTC proposal gets mixed reviews
Roche ends dalcetrapib trial, questions linger on CETP class
Docs trust ED drugs above all, go with their emotions when prescribing
Nurses get their own app with Lippincott launch
Harvard urges faculty to ditch journals
Massachusetts gift ban under attack (again)
Enbrel reps risk layoff, as Pfizer calls early end to US selling
Pharma Report 2012: Get Back in Shape
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Pfizer, Crestor tops for global promotional spend in 2011
Wolters Kluwer deals health analytics unit to private equity firm
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Med Ed Report: Show Me the Money
Bydureon catching on among endos but low profits expected, Amylin says
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Sales forces shrank in 2011, but not everywhere
National plan seeks Alzheimer's treatment by 2025
Coach vs. cancer in BMS-backed awareness effort
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
Siding with Lilly, appeals court overturns decision in rep overtime case
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Popular Topics
Acquisition
Adherence
Agency
App
Conflict Of Interest
Digital
Direct To Consumer (DTC)
Downsize
Education & Awareness
FDA
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Mobile
Obesity
Oncology
Payers
PBMs
Physicians
Rebranding
REMS
Sales Force